Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592787 | SCV000703297 | uncertain significance | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001241564 | SCV001414591 | uncertain significance | Peroxisome biogenesis disorder 2B | 2023-12-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 77 of the PEX5 protein (p.Arg77His). This variant is present in population databases (rs780957318, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with PEX5-related conditions. ClinVar contains an entry for this variant (Variation ID: 498328). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Elsea Laboratory, |
RCV001250064 | SCV001424269 | uncertain significance | Peroxisome biogenesis disorder 2B; Peroxisome biogenesis disorder 2A (Zellweger); Rhizomelic chondrodysplasia punctata type 5 | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001250064 | SCV002800099 | uncertain significance | Peroxisome biogenesis disorder 2B; Peroxisome biogenesis disorder 2A (Zellweger); Rhizomelic chondrodysplasia punctata type 5 | 2021-09-01 | criteria provided, single submitter | clinical testing |